303 related articles for article (PubMed ID: 29779165)
1. The Association of Statin Therapy with Incident Diabetes: Evidence, Mechanisms, and Recommendations.
Agarwala A; Kulkarni S; Maddox T
Curr Cardiol Rep; 2018 May; 20(7):50. PubMed ID: 29779165
[TBL] [Abstract][Full Text] [Related]
2. Statin use and risk for type 2 diabetes: what clinicians should know.
Maki KC; Diwadkar-Navsariwala V; Kramer MW
Postgrad Med; 2018 Mar; 130(2):166-172. PubMed ID: 29139315
[TBL] [Abstract][Full Text] [Related]
3. Statin-associated incident diabetes: a literature review.
Park ZH; Juska A; Dyakov D; Patel RV
Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
[TBL] [Abstract][Full Text] [Related]
4. Diabetes Secondary to Treatment with Statins.
Laakso M; Kuusisto J
Curr Diab Rep; 2017 Feb; 17(2):10. PubMed ID: 28155189
[TBL] [Abstract][Full Text] [Related]
5. Diabetogenic Action of Statins: Mechanisms.
Carmena R; Betteridge DJ
Curr Atheroscler Rep; 2019 Apr; 21(6):23. PubMed ID: 31037345
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?
Chan DC; Pang J; Watts GF
Curr Atheroscler Rep; 2015 Jan; 17(1):472. PubMed ID: 25398645
[TBL] [Abstract][Full Text] [Related]
7. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
[TBL] [Abstract][Full Text] [Related]
8. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
[TBL] [Abstract][Full Text] [Related]
9. Impact of incident diabetes on atherosclerotic cardiovascular disease according to statin use history among postmenopausal women.
Ma Y; Persuitte GM; Andrews C; Hovey KM; LaMonte MJ; Culver AL; Manson JE; Phillips LS; Liu S; Eaton C; Martin LW; Howard BV; Balasubramanian R; Bird CE; Ockene IS; Sturgeon SR; Ockene JK; Tinker L; Nassir R; Rossouw J
Eur J Epidemiol; 2016 Aug; 31(8):747-61. PubMed ID: 27188186
[TBL] [Abstract][Full Text] [Related]
10. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.
Steen DL; Khan I; Ansell D; Sanchez RJ; Ray KK
BMJ Open; 2017 Feb; 7(2):e013255. PubMed ID: 28213597
[TBL] [Abstract][Full Text] [Related]
11. [Statin treatment causes an increased risk of type 2 diabetes].
Solis AB; Pilemann-Lyberg S; Gæde P
Ugeskr Laeger; 2014 Feb; 176(3):227-31. PubMed ID: 24629749
[TBL] [Abstract][Full Text] [Related]
12. Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality.
Lavie G; Hoshen M; Leibowitz M; Benis A; Akriv A; Balicer R; Reges O
Am J Med; 2021 May; 134(5):643-652. PubMed ID: 33217370
[TBL] [Abstract][Full Text] [Related]
13. Statins and diabetes risk: how real is it and what are the mechanisms?
Robinson JG
Curr Opin Lipidol; 2015 Jun; 26(3):228-35. PubMed ID: 25887679
[TBL] [Abstract][Full Text] [Related]
14. Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease.
van de Woestijne AP; van der Graaf Y; Westerink J; Nathoe HM; Visseren FL
Am J Cardiol; 2015 Feb; 115(4):441-6. PubMed ID: 25554536
[TBL] [Abstract][Full Text] [Related]
15. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials.
Sattar N; Preiss D; Murray HM; Welsh P; Buckley BM; de Craen AJ; Seshasai SR; McMurray JJ; Freeman DJ; Jukema JW; Macfarlane PW; Packard CJ; Stott DJ; Westendorp RG; Shepherd J; Davis BR; Pressel SL; Marchioli R; Marfisi RM; Maggioni AP; Tavazzi L; Tognoni G; Kjekshus J; Pedersen TR; Cook TJ; Gotto AM; Clearfield MB; Downs JR; Nakamura H; Ohashi Y; Mizuno K; Ray KK; Ford I
Lancet; 2010 Feb; 375(9716):735-42. PubMed ID: 20167359
[TBL] [Abstract][Full Text] [Related]
16. Statins and new-onset diabetes.
Barylski M; Nikolic D; Banach M; Toth PP; Montalto G; Rizzo M
Curr Pharm Des; 2014; 20(22):3657-64. PubMed ID: 24040871
[TBL] [Abstract][Full Text] [Related]
17. Is statin-induced diabetes clinically relevant? A comprehensive review of the literature.
Bell DS; DiNicolantonio JJ; O'Keefe JH
Diabetes Obes Metab; 2014 Aug; 16(8):689-94. PubMed ID: 24373206
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
[TBL] [Abstract][Full Text] [Related]
19. Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?
Navarese EP; Szczesniak A; Kolodziejczak M; Gorny B; Kubica J; Suryapranata H
Am J Cardiovasc Drugs; 2014 Apr; 14(2):79-87. PubMed ID: 24174174
[TBL] [Abstract][Full Text] [Related]
20. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
